U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Excitatory Amino Acid Antagonists [Pharmacological Action]

Tree Number(s): D018691

MeSH Unique ID: D018691

  • 2-amino-3-phosphonopropionic acid (Supplementary Concept)
  • caroverine (Supplementary Concept)
  • 1-hydroxy-3-amino-2-pyrrolidone (Supplementary Concept)
  • ifenprodil (Supplementary Concept)
  • glutamic acid diethyl ester (Supplementary Concept)
  • ketobemidone (Supplementary Concept)
  • 2,3-piperidinedicarboxylic acid (Supplementary Concept)
  • 2-amino-7-phosphonoheptanoic acid (Supplementary Concept)
  • carbinoxamine, dextromethorphan, pseudoephedrine drug combination (Supplementary Concept)
  • 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (Supplementary Concept)
  • selfotel (Supplementary Concept)
  • conotoxin GV (Supplementary Concept)
  • FG 9041 (Supplementary Concept)
  • 7-chlorokynurenic acid (Supplementary Concept)
  • eliprodil (Supplementary Concept)
  • NPC 12626 (Supplementary Concept)
  • GYKI 52466 (Supplementary Concept)
  • HU 211 (Supplementary Concept)
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (Supplementary Concept)
  • conantokin-T (Supplementary Concept)
  • 2-amino-4-methyl-5-phosphono-3-pentenoic acid (Supplementary Concept)
  • CGP 39551 (Supplementary Concept)
  • SDZ EAA 494 (Supplementary Concept)
  • 5,7-dichlorokynurenic acid (Supplementary Concept)
  • CGP 39653 (Supplementary Concept)
  • gacyclidine (Supplementary Concept)
  • 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline (Supplementary Concept)
  • 3,5-dihydroxyphenylglycine (Supplementary Concept)
  • GYKI 53655 (Supplementary Concept)
  • 4-carboxyphenylglycine (Supplementary Concept)
  • alpha-methyl-4-carboxyphenylglycine (Supplementary Concept)
  • aptiganel (Supplementary Concept)
  • 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (Supplementary Concept)
  • LY 235959 (Supplementary Concept)
  • licostinel (Supplementary Concept)
  • L 701324 (Supplementary Concept)
  • 1-aminoindan-1,5-dicarboxylic acid (Supplementary Concept)
  • 3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid (Supplementary Concept)
  • LY 341495 (Supplementary Concept)
  • 6-methyl-2-(phenylethynyl)pyridine (Supplementary Concept)
  • kaitocephalin (Supplementary Concept)
  • 2-amino-3-((3,4-difluorophenyl)sulfanylmethyl)-4-hydroxy-bicyclo(3.1.0)hexane-2,6-dicarboxylic acid hydrochloride (Supplementary Concept)
  • 2-Oxo-PCE (Supplementary Concept)
  • 2-(1,1-dimethyl-1,3-dihydro-benzo(e)indol-2-ylidene)-malonaldehyde (Supplementary Concept)
  • BCI-838 (Supplementary Concept)
  • Dextromethorphan (MeSH Term)
  • Dextrorphan (MeSH Term)
  • Ibogaine (MeSH Term)
  • Ketamine (MeSH Term)
  • Kynurenic Acid (MeSH Term)
  • Memantine (MeSH Term)
  • Phencyclidine (MeSH Term)
  • Phenobarbital (MeSH Term)
  • 2-Aminoadipic Acid (MeSH Term)
  • 2-Amino-5-phosphonovalerate (MeSH Term)
  • Dizocilpine Maleate (MeSH Term)
  • 6-Cyano-7-nitroquinoxaline-2,3-dione (MeSH Term)
  • Riluzole (MeSH Term)
  • Gabapentin (MeSH Term)
  • Felbamate (MeSH Term)

Supplemental Content

Loading ...